Endosomal/lysosomal retention and degradation of major histocompatibility complex class I molecules is induced by Myxoma virus

Virology

Volumn 261, Issue 2, 1999, Pages 180-192

  Zúñiga, Martha C ^a   Wang, Hong ^a   Barry, Michele ^b   McFadden, Grant ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; AMMONIUM CHLORIDE; BETA 2 MICROGLOBULIN; CYTARABINE; GENE PRODUCT; LEUPEPTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ARTICLE; CELL ORGANELLE; CELL SURFACE; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; GOLGI COMPLEX; IMMUNOFLUORESCENCE MICROSCOPY; LEPORIPOXVIRUS; LYSOSOME; MONKEY; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN TARGETING; RABBIT;

ANIMALIA; CERCOPITHECUS AETHIOPS; DNA VIRUSES; LEPORIPOXVIRUS; MYXOMA VIRUS; ORYCTOLAGUS CUNICULUS; POXVIRIDAE;

EID: 19244367349     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9840     Document Type: Article

References (60)

1. Abdel Motal U. M., Zhou X., Joki A., Siddiqi A. R., Srinivasa B. R., Stenvall K., Dahmen J., Jondal M. Major histocompatibility complex class I-binding peptides are recycled to the cell surface after internalization. Eur. J. Immunol. 23:1993;3224-3229.
2. Ahn K., Angulo A., Ghazal P., Peterson P. A., Yang Y., Fruh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA. 93:1996a;10990-10995.
3. Ahn K., Gruhler A., Galocha B., Jones T. R., Wiertz E. J., Ploegh H. L., Peterson P. A., Yang Y., Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 6:1997;613-621.
4. Ahn K., Meyer T. H., Uebel S., Sempe P., Djaballah H., Yang Y., Peterson P. A., Fruh K., Tampe R. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 15:1996b;3247-3255.
5. Akasaki K., Michihara A., Mibuka K., Fujiwara Y., Tsuji H. Biosynthetic transport of a major lysosomal membrane glycoprotein, lamp-1: Convergence of biosynthetic and endocytic pathways occurs at three distinctive points. Exp. Cell Res. 220:1995;464-473.
6. Andersson M., Paabo S., Nilsson T., Peterson P. A. Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell. 43:1985;215-222.
7. Barnstable C. J., Bodmer W. F., Brown G., Galfre G., Milstein C., Williams A. F., Ziegler A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell. 14:1978;9-20.
8. Barry M., Hnatiuk S., Mossman K., Lee S. F., Boshkov L., McFadden G. The myxoma virus M-T4 gene encodes a novel RDEL-containing protein that is retained within the endoplasmic reticulum and is important for the productive infection of lymphocytes. Virology. 239:1997;360-377.
9. + T lymphocytes. J. Virol. 69:1995;5243-5251.
10. Beltzer J. P., Spiess M. In vitro binding of the asialoglycoprotein receptor to the beta adaptin of plasma membrane coated vesicles. EMBO J. 10:1991;3735-3742.
11. Bogyo M., McMaster J. S., Gaczynska M., Tortorella D., Goldberg A. L., Ploegh H. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. Proc. Natl. Acad. Sci. USA. 94:1997;6629-6634.
12. Boshkov L. K., Macen J. L., McFadden G. Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus. J. Immunol. 148:1992;881-887.
13. Burgert H. G., Kvist S. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell. 41:1985;987-997.
14. Capps G. G., Robinson B. E., Lewis K. D., Zúñiga M. C. In vivo dimeric association of class I MHC heavy chains: Possible relationship to class I MHC heavy chain-beta 2-microglobulin dissociation. J. Immunol. 151:1993;159-169.
15. Capps G. G., Van Kampen M., Ward C. L., Zúñiga M. C. Endocytosis of the class I major histocompatibility antigen via a phorbol myristate acetate-inducible pathway is a cell-specific phenomenon and requires the cytoplasmic domain [published erratum appears in J. Cell Biol. 1989 Sep;109(3):1381]. J. Cell Biol. 108:1989;1317-1329.
16. Carlsson S. R., Roth J., Piller F., Fukuda M. Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycan. J. Biol. Chem. 263:1988;18911-18919.
17. Clague M. J., Urbe S., Aniento F., Gruenberg J. Vacuolar ATPase activity is required for endosomal carrier vesicle formation. J. Biol. Chem. 269:1994;21-24.
18. Cox J. H., Bennink J. R., Yewdell J. W. Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J. Exp. Med. 174:1991;1629-1637.
19. Fruh K., Ahn K., Djaballah H., Sempe P., van Endert P. M., Tampe R., Peterson P. A., Yang Y. A viral inhibitor of peptide transporters for antigen presentation. Nature. 375:1995;415-418.
20. Fuller S. D., Simons K. Transferrin receptor polarity and recycling accuracy in "tight" and "leaky" strains of Madin-Darby canine kidney cells. J. Cell Biol. 103:1986;1767-1779.
21. Glickman J. N., Conibear E., Pearse B. M. Specificity of binding of clathrin adaptors to signals on the mannose-6-phosphate/insulin-like growth factor II receptor. EMBO J. 8:1989;1041-1047.
22. Greenberg M. E., Iafrate A. J., Skowronski J. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 17:1998;2777-2789.
23. Heemels M. T., Ploegh H. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:1995;463-491.
24. Hengel H., Flohr T., Hammerling G. J., Koszinowski U. H., Momburg F. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. J. Gen. Virol. 77:1996;2287-2296.
25. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature. 375:1995;411-415.
26. Jones T. R., Sun L. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J. Virol. 71:1997;2970-2979.
27. Jones T. R., Wiertz E. J., Sun L., Fish K. N., Nelson J. A., Ploegh H. L. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. USA. 93:1996;11327-11333.
28. Le Gall S., Erdtmann L., Benichou S., Berlioz-Torrent C., Liu L., Benarous R., Heard J. M., Schwartz O. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity. 8:1998;483-495.
29. Le Guern A., Wetterskog D., Marche P. N., Kindt T. J. A monoclonal antibody directed against a synthetic peptide reacts with a cell surface rabbit class I MHC molecule. Mol. Immunol. 24:1987;455-461.
30. Lehner P. J., Cresswell P. Processing and delivery of peptides presented by MHC class I molecules. Curr. Opin. Immunol. 8:1996;59-67.
31. Levitt J., Becker Y. The effect of cytosine arabinoside on the replication of herpes simplex virus. Virology. 31:1967;129-134.
32. Luo T., Anderson S. J., Garcia J. V. Inhibition of Nef- and phorbol ester-induced CD4 degradation by macrolide antibiotics. J. Virol. 70:1996;1527-1534.
33. Madden D. R. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:1995;587-622.
34. Mangasarian A., Foti M., Aiken C., Chin D., Carpentier J. L., Trono D. The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. Immunity. 6:1997;67-77.
35. May W. S. Jr., Cuatrecasas P. Transferrin receptor: its biological significance. J. Membr. Biol. 88:1985;205-215.
36. McFadden G. Even viruses can learn to cope with stress [comment]. Science. 279:1998;40-41.
37. McFadden G., Graham K., Barry M. New strategies of immune modulation by DNA viruses. Transplant. Proc. 28:1996;2085-2088.
38. McFadden G., Graham K., Ellison K., Barry M., Macen J., Schreiber M., Mossman K., Nash P., Lalani A., Everett H. Interruption of cytokine networks by poxviruses: lessons from myxoma virus. J. Leukoc. Biol. 57:1995;731-738.
39. McFadden G., Kane K. How DNA viruses perturb functional MHC expression to alter immune recognition. Adv. Cancer Res. 63:1994;117-209.
40. Mossman K., Lee S. F., Barry M., Boshkov L., McFadden G. Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J. Virol. 70:1996a;4394-4410.
41. Mossman K., Nation P., Macen J., Garbutt M., Lucas A., McFadden G. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology. 215:1996b;17-30.
42. Opgenorth A., Graham K., Nation N., Strayer D., McFadden G. Deletion analysis of two tandemly arranged virulence genes in myxoma virus, M11L and myxoma growth factor. J. Virol. 66:1992;4720-4731.
43. Ozato K., Hansen T. H., Sachs D. H. Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J. Immunol. 125:1980;2473-2477.
44. Ploegh H. L. Viral strategies of immune evasion. Science. 280:1998;248-253.
45. Rabinowitz S., Horstmann H., Gordon S., Griffiths G. Immunocytochemical characterization of the endocytic and phagolysosomal compartments in peritoneal macrophages. J. Cell Biol. 116:1992;95-112.
46. Reaves B., Banting G. Vacuolar ATPase inactivation blocks recycling to the trans-Golgi network from the plasma membrane. FEBS Lett. 345:1994;61-66.
47. Reid P. A., Watts C. Cycling of cell surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature. 346:1990;655-657.
48. Reusch U., Muranyi W., Lufin P., Burgert H.-G., Hengel H., Koszinowski U. H. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 18:1999;1081-1091.
49. Schwartz O., Marechal V., Le Gall S., Lemonnier F., Heard J. M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:1996;338-342.
50. Tomazin R., Hill A. B., Jugovic P., York I., van Endert P., Ploegh H. L., Andrews D. W., Johnson D. C. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 15:1996;3256-3266.
51. van Weert A. W., Dunn K. W., Gueze H. J., Maxfield F. R., Stoorvogel W. Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump. J. Cell Biol. 130:1995;821-834.
52. Wiertz E. J., Jones T. R., Sun L., Bogyo M., Geuze H. J., Ploegh H. L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell. 84:1996;769-779.
53. Woo J. T., Shinohara C., Sakai K., Hasumi K., Endo A. Inhibition of the acidification of endosomes and lysosomes by the antibiotic concanamycin B in macrophage J774. Eur. J. Biochem. 207:1992a;383-389.
54. Woo J. T., Shinohara C., Sakai K., Hasumi K., Endo A. Isolation, characterization and biological activities of concanamycins as inhibitors of lysosomal acidification. J. Antibiot. (Tokyo). 45:1992b;1108-1116.
55. Yewdell J. W., Bennink J. R. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1992;1-123.
56. York I. A., Rock K. L. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:1996;369-396.
57. York I. A., Roop C., Andrews D. W., Riddell S. R., Graham F. L., Johnson D. C. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell. 77:1994;525-535.
58. Zúñiga M. C., Hood L. E. Clonal variation in cell surface display of an H-2 protein lacking a cytoplasmic tail. J. Cell Biol. 102:1986;1-10.
59. Zúñiga M. C., Malissen B., McMillan M., Brayton P. R., Clark S. S., Forman J., Hood L. Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. Cell. 34:1983;535-544.
60. Zúñiga M. C., Wang H., Barry M., McFadden G. Myxoma virus abrogates cell surface expression of MHC I by multiple mechanisms. Jameel S., Villarreal L. P. Advances in Virus Research. 1999;IBH Publishing Co. Oxford, New Delhi.